RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Tamir Biotechnology, Inc – Product Pipeline Review – Q4 2010
Dec 2010 - 15 pages - $500
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
Gene Signal International SA. – Product Pipeline Review – Q1 2011
Mar 2011 - 34 pages - $500
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
Dec 2009 - 90 pages - $3,800
Coldwell Banker Gene Armstrong, Inc. - Company Capsule
Nov 2011 - 6 pages - $75
Phage Biotechnology Corporation – Product Pipeline Review – Q4 2010
Dec 2010 - 25 pages - $500
Avir Green Hills Biotechnology AG – Product Pipeline Review – Q1 2011
Mar 2011 - 26 pages - $500
N-Gene Research Laboratories, Inc.-Therapeutic Competitors Report
Nov 2010 - 56 pages - $600
Gene Signal International SA-Therapeutic Competitors Report
Nov 2010 - 88 pages - $600
Prana Biotechnology Limited – Product Pipeline Review – Q1 2011
Mar 2011 - 42 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Gene therapy del
Therapeutic target
Other therapeutic del

Browse By

Therapeutic target
Ayuverdic medicine
Chinese medicine
Dietetic
Homeopathy
Iron excess
Kanpo medicine
Other
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us